Kobe, C., Scheffler, M., Holstein, A., Zander, T., Nogova, L., Lammertsma, A., . . . Kahraman, D. (2012). Predictive value of early and late residual F-fluorodeoxyglucose and F-fluorothymidine uptake using different SUV measurements in patients with non-small-cell lung cancer treated with erlotinib. European Journal of Nuclear Medicine & Molecular Imaging, 39(7), 1117-1128.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita Chicago Style (17a ed.)
Kobe, Carsten, et al. "Predictive Value of Early and Late Residual F-fluorodeoxyglucose and F-fluorothymidine Uptake Using Different SUV Measurements in Patients with Non-small-cell Lung Cancer Treated with Erlotinib."
European Journal of Nuclear Medicine & Molecular Imaging 39, no. 7 (2012): 1117-1128.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita MLA (9a ed.)
Kobe, Carsten, et al. "Predictive Value of Early and Late Residual F-fluorodeoxyglucose and F-fluorothymidine Uptake Using Different SUV Measurements in Patients with Non-small-cell Lung Cancer Treated with Erlotinib."
European Journal of Nuclear Medicine & Molecular Imaging, vol. 39, no. 7, 2012, pp. 1117-1128.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Precaución: Estas citas no son 100% exactas.